Company Badge
USPTO Data Jan 1 1976 - Nov 3 2026
9 Patents
#767 in New York, NY
#1,908 in New York
#32,649 in US
Arixa Pharmaceuticals, Inc.
Forward Citations = 10
6 inventors:
New York, NY, United States of America
Arixa Pharmaceuticals, Inc.
Calculating rank
% Expired Patents = 22.2
CIPO Patents = 2
EPO Patents = 3
Forward Citations = 10
Loading Chart...
Loading Chart...
6 inventors (with patents filed for the assignee):
Eric M Gordon (8 out of 100 patents)
John Freund (7 out of 7 patents)
Matthew A J Duncton (4 out of 4 patents)
4. Matthew Alexander James Duncton (3 out of 3 patents)
5. Mark A Gallop (3 out of 107 patents)
6. Sami Karaborni (1 out of 30 patents)
7. Carole Sable (0 patent)
8. Matthew A Duncton (0 patent)
9. Joaquim Trias (0 patent)
10. Andrew Nicholls (0 patent)
11. Matthew Aj Duncton (0 patent)
9 patents:
Company Overview
Arixa Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel therapies for the treatment of various diseases. With a strong pipeline of innovative drug candidates, Arixa is dedicated to improving patient outcomes and addressing unmet medical needs. The company's mission is to bring life-changing treatments to market through cutting-edge research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Arixa Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/arixa-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]